308 related articles for article (PubMed ID: 27545990)
1. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.
Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990
[TBL] [Abstract][Full Text] [Related]
2. Impaired emotional state, quality of life and cognitive functions in young hypogonadal men.
Lašaitė L; Ceponis J; Preikša RT; Zilaitienė B
Andrologia; 2014 Dec; 46(10):1107-12. PubMed ID: 24313565
[TBL] [Abstract][Full Text] [Related]
3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement in older men and women.
Morley JE
J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies.
Belkoff L; Brock G; Carrara D; Neijber A; Ando M; Mitchel J
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28295450
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions.
Aydogan U; Aydogdu A; Akbulut H; Sonmez A; Yuksel S; Basaran Y; Uzun O; Bolu E; Saglam K
Endocr J; 2012; 59(12):1099-105. PubMed ID: 22972022
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment patterns of testosterone replacement medications.
Donatucci C; Cui Z; Fang Y; Muram D
J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
[TBL] [Abstract][Full Text] [Related]
10. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
[TBL] [Abstract][Full Text] [Related]
11. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
12. Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial.
Gregori G; Celli A; Barnouin Y; Paudyal A; Armamento-Villareal R; Napoli N; Qualls C; Villareal DT
Am J Clin Nutr; 2021 Nov; 114(5):1590-1599. PubMed ID: 34375393
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
[TBL] [Abstract][Full Text] [Related]
15. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
Yassin AA; Nettleship J; Almehmadi Y; Salman M; Saad F
Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
[TBL] [Abstract][Full Text] [Related]
16. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
[TBL] [Abstract][Full Text] [Related]
17. The effects of treating male hypogonadism on couples' sexual desire and function.
Conaglen JV; Conaglen HM
J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
[TBL] [Abstract][Full Text] [Related]
19. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
[TBL] [Abstract][Full Text] [Related]
20. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
